Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
6.24
+0.22 (3.65%)
At close: Jun 23, 2026, 4:00 PM EDT
6.00
-0.24 (-3.85%)
After-hours: Jun 23, 2026, 7:54 PM EDT
Silo Pharma Employees
Silo Pharma had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$24,034
Profits / Employee
-$1,614,459
Market Cap
6.77M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - |
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 1 | 50.00% |
| Dec 31, 2021 | 2 | 1 | 100.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| NextCure | 40 |
| PMGC Holdings | 34 |
| Purple Biotech | 10 |
| CNS Pharmaceuticals | 8 |
| Ernexa Therapeutics | 7 |
| Can-Fite BioPharma | 5 |
| Acurx Pharmaceuticals | 4 |
SILO News
- 13 hours ago - Silo Pharma reports positive stability data for stress treatment SPC-15 - TheFly
- 16 hours ago - Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial - GlobeNewsWire
- 5 days ago - Silo Pharma regains compliance with Nasdaq min bid price requirement - TheFly
- 5 days ago - Silo Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 21 days ago - Silo Pharma Inc trading halted, news pending - TheFly
- 6 weeks ago - Silo Pharma files provisional patent for ibogaine-based therapeutics - TheFly
- 6 weeks ago - Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury - GlobeNewsWire
- 7 weeks ago - Silo Pharma's PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD - GlobeNewsWire